The role of ISCHEMIA in stable ischemic heart disease

Area of Science:

• Cardiology
• Clinical Trials
• Ischemic Heart Disease

Background:

• Early revascularization improves outcomes in acute coronary syndrome (ACS).
• Evidence for intervention benefits in stable ischemic heart disease (SIHD) is less clear.
• Optimal medical therapy (OMT) is the standard of care for SIHD.

Purpose of the Study:

• To evaluate the effectiveness of invasive strategies compared to OMT alone in SIHD patients.
• To determine if initial catheterization and revascularization offer benefits beyond OMT.
• To assess outcomes in patients with moderate to severe ischemia on stress testing.

Main Methods:

• The International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial.
• Randomized controlled trial comparing invasive (catheterization + revascularization) vs. conservative (OMT) strategies.
• Inclusion of patients with stable ischemic heart disease and at least moderate ischemia.

Main Results:

• No significant difference in mortality or myocardial infarction between invasive and conservative strategies.
• Optimal medical therapy alone provided comparable outcomes to early invasive procedures.
• Stress testing identified patients with moderate to severe ischemia but did not predict differential treatment benefit.

Conclusions:

• For patients with stable ischemic heart disease and moderate to severe ischemia, optimal medical therapy is sufficient.
• Routine early catheterization and revascularization do not offer additional benefits over OMT in this population.
• Focus should remain on optimizing medical therapy for SIHD patients without high-risk ACS features.